DISTINCT ANTI-TUMOR RESPONSE TO LISTERIA-BASED VACCINES BETWEEN ORTHOTOPIC AND SUBCUTANEOUS SYNGENEIC MOUSE MODELS OF RENAL CELL CARCINOMA

被引：0
|
作者：
Nguyen, Hong-My [1 ]
Wood, Laurence [1 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Abilene, TX USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.1370
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1370
引用
收藏
页码：A1422 / A1423
页数：2
相关论文
共 34 条
  • [31] Synergy between Dendritic Cell-Based Vaccine and Anti-CD137 Monoclonal Antibody in the Treatment of Mouse Renal Cell Carcinoma
    Wei, Si-Ming
    Yan, Zhi-Zhong
    Zhou, Jian
    KUWAIT MEDICAL JOURNAL, 2012, 44 (04): : 308 - 315
  • [32] PRO1160, a novel CD70-directed antibody-drug conjugate, demonstrates robust anti-tumor activity in mouse models of renal cell carcinoma and non-Hodgkin lymphoma
    Wang, Lei
    Liu, Haidong
    Shang, Xiao
    Han, Tae
    Zhao, Baiteng
    CANCER RESEARCH, 2022, 82 (12)
  • [33] Distinct gene expression profiles and cell death pathways in clear-cell renal cell carcinoma (CCRCC) and colorectal carcinoma (CRC) cells: relationship to hypoxia, von Hippel Lindau protein (pVHL) expression and anti-tumor activity of sorafenib
    Ganapathi, R.
    AI-Hazzouri, A.
    Vaziri, S.
    Grabowski, D.
    Bukowski, R.
    EJC SUPPLEMENTS, 2006, 4 (12): : 18 - 19
  • [34] Agonistic cd40 antibodies inhibit murine renal cell carcinoma cells in vitro, provide anti-tumor effects in resting mice, but result in significant toxicity after syngeneic bone marrow transplantation: Potential therapeutic considerations.
    Shaaban, AF
    Kim, HB
    Milner, R
    Hayashi, S
    Fichter, C
    Flake, AW
    BLOOD, 1999, 94 (10) : 322A - 322A
1234